Clinical trials
Phase 1/2 Lymphoma, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
142 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 5 |
| 2016 | 9 |
| 2017 | 11 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 14 |
| 2023 | 11 |
| 2024 | 10 |
| 2025 | 8 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Recruiting | 34 |
| Unknown status | 28 |
| Terminated | 16 |
| Withdrawn | 12 |
| Active, not recruiting | 11 |
| Not yet recruiting | 4 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 7 |
| Chongqing Precision Biotech Co., Ltd | 4 |
| Chinese PLA General Hospital | 3 |
| Fred Hutchinson Cancer Center | 3 |
| Gilead Sciences | 3 |
| Hoffmann-La Roche | 3 |
| Shenzhen University General Hospital | 3 |
| Wuhan Sian Medical Technology Co., Ltd | 3 |
| Alopexx Oncology, LLC | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 142 |
| Lymphoma, Non-Hodgkin | 39 |
| Lymphoma | 35 |
| Lymphoma, Large B-Cell, Diffuse | 32 |
| Lymphoma, Follicular | 25 |
| Recurrence | 25 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 23 |
| Lymphoma, Mantle-Cell | 23 |
| Leukemia, B-Cell | 19 |
| Burkitt Lymphoma | 14 |
Trials
Showing 51 to 75 of 142. Each trial links to its page on Pharma Observatory.
42 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.